Skip to content

Search

Showing results for " https://www.galaxus.ch/en/sector/showdiscussion/hack-someone-snap-visit-kunghaccom-j8f6qlhn-224830"

Trimodal skin health programme for childhood impetigo control in remote Western Australia (SToP): a cluster randomised, stepped-wedge trial

Skin infections affect physical health and, through stigma, social-emotional health. When untreated, they can cause life-threatening conditions. We aimed to assess the effect of a holistic, co-designed, region-wide skin control programme on the prevalence of impetigo.

Preparing for school in 2024

It's the new school year and by now your child's school should have a copy of their updated Diabetes Management Plan. Adele Connor, Diabetes in

In other news ....

Diabetes-related news, funding announcements and our latest published research.

Diabetes clinic: We've moved

With a little over a week before outpatient clinics move from Princess Margaret Hospital (PMH) to Perth Children’s Hospital (PCH), now is the time to familiarise yourself with all the information you need to know before you make your first visit.

Mums' gut bacteria linked to babies’ health

Evidence is mounting that the bacteria in a mother’s digestive system, known as microbiome, can influence the health of babies.

ENDIA milestone

The ENDIA study — Australia’s largest study into the causes of Type 1 Diabetes— reached a significant milestone when it recruited its 700th patient in Perth.

National Antimicrobial Surveillance Academy for Indigenous Health Care Providers

Asha Bowen BA MBBS DCH FRACP PhD GAICD FAHMS OAM Head, Healthy Skin and ARF Prevention Head, Healthy Skin and ARF Prevention Areas of expertise: Skin

ENVISAGE Term 3 programs

ENVISAGE is a free peer support program specifically designed for parents and caregivers of children aged 0-8 years with disabilities or developmental concerns. Term 3 dates now released.

Insulin and Abatacept trial in type 1 diabetes

Diabetes researchers from The Kids Research Institute Australia and Perth Children’s Hospital are excited to be taking part in the national Insulin

Long-term antipsychotic use and cardiometabolic adverse effects in adults with non-psychotic disorders: A systematic review

Off-label antipsychotic prescribing for non-psychotic disorders is increasing, often at low doses and over extended periods. While cardiometabolic adverse effects are documented among individuals treated with antipsychotics for psychotic disorders, the consequences of long-term off-label antipsychotic use are not well-known.